Mammography Market Report 2026

The mammography market size has grown strongly in recent years. It will grow from $2.88 billion in 2025 to $3.17 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increase in breast cancer incidence rates, widespread adoption of x-ray imaging techniques, government-led breast cancer awareness programs, availability of film screen mammography systems, expansion of hospital-based diagnostic imaging.

The mammography market size is expected to see rapid growth in the next few years. It will grow to $4.65 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growth of population-based screening initiatives, rising investments in women’s health diagnostics, increasing preference for early and accurate detection, technological shift toward digital and tomosynthesis imaging, improving healthcare infrastructure in developing regions. Major trends in the forecast period include rising adoption of digital and 3D mammography systems, growing focus on early breast cancer screening programs, increased use of portable mammography in remote settings, higher demand for minimally invasive breast biopsy integration, expansion of screening services in emerging healthcare markets.

The rising incidence of breast cancer is expected to drive the growth of the mammography market. Breast cancer is a condition in which the cells of the breast grow uncontrollably. The prevalence of breast cancer is increasing worldwide, and mammography is one of the most effective and widely used screening tools for early detection and diagnosis of breast cancer. For example, in 2023, according to Breastcancer.org, a U.S.-based nonprofit organization, an estimated 297,790 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, along with 55,720 new cases of DCIS. Additionally, in January 2023, according to the American Cancer Society, a U.S.-based voluntary organization, in 2022, approximately 287,850 new cases of invasive breast cancer were identified in women in the United States, along with 51,400 new cases of non-invasive (in situ) breast cancer. Therefore, the rising incidence of breast cancer is fueling the growth of the mammography market.

Major companies operating in the mammography market are emphasizing advancements such as pilot programs for mammography services to promote early detection of breast cancer, improve patient outcomes, and expand access to underserved populations through mobile screening units and AI-assisted diagnostic tools. These efforts aim to enhance accuracy, shorten diagnostic times, and make mammography more accessible to remote and economically disadvantaged areas, ultimately supporting greater healthcare equity. For example, in December 2023, RadNet, Inc., a US-based healthcare company, launched a pilot program called MammogramNow, providing mammography services within Walmart Supercenters. This program seeks to raise breast health awareness and accessibility by integrating advanced DeepHealth AI technology into a retail environment, making breast cancer screening more convenient. MammogramNow allows walk-in appointments with screenings completed in roughly 15 minutes. Patients can also choose AI-assisted screenings through RadNet’s DeepHealth subsidiary for enhanced detection accuracy. By offering healthcare services in everyday retail settings, RadNet and Walmart aim to transform preventive healthcare delivery and accessibility in the US.

In April 2024, Solis Mammography, a US-based healthcare company, partnered with Northwest Healthcare to enhance breast imaging services in the Tucson area. This collaboration is designed to expand access to essential mammography services, which are critical for early breast cancer detection, particularly for women over 40, who are at higher risk. Northwest Healthcare, a US-based healthcare company, focuses on delivering high-quality, accessible healthcare to the local community, further reinforcing this initiative.

Major companies operating in the mammography market are Hologic Inc., Fujifilm Corporation, Siemens Healthcare AG, Canon Medical Systems Corporation, GE Healthcare Company, Koninklijke Philips N.V., Metaltronica S.p.A., PLANMED OY, Villa Sistemi Medicali S.p.A., Carestream Health, Konica Minolta Inc., Agfa-Gevaert N.V., Delphinus Medical Technologies Inc., Micrima Limited, Koning Corporation, Allengers Medical Systems Ltd., Trivitron Healthcare Pvt. Ltd., Genoray Co. Ltd., Analogic Corporation, BMI Biomedical International s.r.l., General Medical Merate S.p.A., IMS Srl, Medi-Future Co. Ltd., PerkinElmer Inc., QView Medical Inc., Radmirtech Co. Ltd.

North America was the largest region in the mammography market in 2025. The regions covered in the mammography market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mammography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have had a moderate impact on the mammography market by increasing the cost of imported imaging equipment, detectors, and electronic components. Digital and 3D mammography system segments are most affected, particularly in regions dependent on imported medical devices such as asia-pacific and latin america. These tariffs may slow equipment upgrades for smaller diagnostic centers. However, they are also encouraging local manufacturing and regional assembly of mammography systems, supporting long-term market resilience.

The mammography market research report is one of a series of new reports that provides mammography market statistics, including mammography industry global market size, regional shares, competitors with a mammography market share, detailed mammography market segments, market trends and opportunities, and any further data you may need to thrive in the mammography industry. This mammography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mammography is a diagnostic X-ray imaging method used to examine breast tissue for the early detection of malignancies, breast cancer, and other breast conditions. It serves as both a screening and diagnostic tool.

The primary types of mammography products include film screen systems, digital systems, analog systems, biopsy systems, 3D systems, and others. Film screen mammography is an imaging technique that captures pictures of breast tissue on X-ray film and stores them. This method involves compressing the breast between two plates, exposing it to X-rays, and developing the image on specialized film.

The mammography market includes revenues earned by entities by screening mammography, diagnostic mammography, digital mammography, and breast ultrasound. The market value includes the value of related goods sold by the service provider or included within the service offering. The mammography market also includes sales of mammography machines, compression paddles and radiographic films. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.